Patel, Nishil
Barnhart, Rebecca
Konkol, Paul
Varda, Josephine
Nelson, Rob
Smith, Tim
Funding for this research was provided by:
Amgen, Inc
Article History
First Online: 5 December 2020
Change Date: 6 January 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40267-020-00810-1
Declarations
:
: This manuscript was supported by Amgen, Inc.
: Nishil Patel: employment with and stock ownership in Amgen Inc. Rebecca Barnhart: no financial support or personal connections that could be perceived to bias her work. Paul Konkol: no financial support or personal connections that could be perceived to bias his work. Josephine Varda: no financial support or personal connections that could be perceived to bias her work. Rob Nelson: employment with and stock ownership in Amgen Inc. Tim Smith: consultant or scientific advisor for Amgen, Biohaven, Impel Neuropharma, Eli Lilly, Lundbeck, Theranica; research support for Allergan, Amgen, Biohaven, Charleston Labs, Eli Lilly, Electrocore, Lundbeck, Novartis, Novo Nordisk, Satsuma, Theranica, Vorso; board member and officer for National Headache Foundation; stock ownership in United Health Group (UNH).
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: The authors attest that they have participated sufficiently in the conception, design, and writing of this manuscript. The authors take public responsibility for the content and agree to be accountable for the accuracy and integrity of this work.